Qmiiz Odt patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8545879 TERSERA Fast disintegrating compositions of meloxicam
Aug, 2030

(6 years from now)

Qmiiz Odt is owned by Tersera.

Qmiiz Odt contains Meloxicam.

Qmiiz Odt has a total of 1 drug patent out of which 0 drug patents have expired.

Qmiiz Odt was authorised for market use on 19 October, 2018.

Qmiiz Odt is available in tablet, orally disintegrating;oral dosage forms.

The generics of Qmiiz Odt are possible to be released after 31 August, 2030.

Drugs and Companies using MELOXICAM ingredient

Market Authorisation Date: 19 October, 2018

Treatment: NA


More Information on Dosage

QMIIZ ODT family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic